Orexigen Therapeutics to Host Conference Call at 8:30 a.m. Eastern Time Today to Discuss Acquisition of U.S. Rights to Contra... Print Alert Orexigen Therapeutics, Inc. (MM) (NASDAQ:OREX) Intraday Stock Chart Today : Tuesday 15 March 2016
Click Here for more Orexigen Therapeutics, Inc. (MM) Charts. SAN DIEGO, March 15, 2016 /PRNewswire/ -- Orexigen Therapeutics, Inc. (Nasdaq: OREX) will host a conference call this afternoon to discuss the strategic acquisition of all U.S. rights to Contrave® and the Mysimba® commercialization and distribution agreement with Valeant Pharmaceuticals International, Inc. for Central and Eastern Europe.
The call will be held today at 8:30 a.m. ET / 5:30 a.m. PT and may be accessed by phone by calling (888) 771-4371 (domestic) or (847) 585-4405 (international), participant code 42093506. The webcast can be accessed live on the Investors section of the Orexigen web site at http://www.orexigen.com, and will be archived for 14 days following the call.
Orexigen Contact:
Media Contact:
McDavid Stilwell
Julie Normart
VP, Corporate Communications and Business Development